Literature DB >> 23907382

Vascular smooth muscle function: defining the diabetic vascular phenotype.

Rosa Maria Bruno1, Lorenzo Ghiadoni.   

Abstract

In this issue of Diabetologia, a meta-analysis performed by Montero and co-authors (Diabetologia doi 10.1007/s00125-013-2974-1 ) demonstrates a significant impairment of vascular smooth muscle (VSM) function in type 2 diabetic patients. Endothelial function and VSM function between type 2 diabetic and healthy individuals were associated, especially in the microcirculation, confirming the hypothesis that unresponsiveness of VSM cells to NO may amplify the consequences of reduced NO availability. This study suggests a novel interpretation for endothelial dysfunction in diabetic patients, indicating VSM cells as key players. Causative mechanisms of VSM dysfunction, which seems to be a feature of the vascular phenotype of type 2 diabetes mellitus, are largely unexplored in humans. Future studies should also address the crucial issue of the prognostic significance of VSM dysfunction in diabetic patients, and possibly in other conditions characterised by high cardiovascular risk.

Entities:  

Mesh:

Year:  2013        PMID: 23907382     DOI: 10.1007/s00125-013-3008-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study.

Authors:  Lorenzo Ghiadoni; Francesco Faita; Massimo Salvetti; Carlo Cordiano; Almerina Biggi; Massimo Puato; Antonio Di Monaco; Luca De Siati; Massimo Volpe; Giuseppe Ambrosio; Vincenzo Gemignani; Maria L Muiesan; Stefano Taddei; Gaetano A Lanza; Francesco Cosentino
Journal:  J Hypertens       Date:  2012-07       Impact factor: 4.844

2.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs; Sidney C Smith; Jeffrey L Anderson; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Rick Nishimura; E Magnus Ohman; Richard L Page; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2010-12-14       Impact factor: 24.094

Review 3.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

Review 4.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

Review 5.  Is oxidative stress a therapeutic target in cardiovascular disease?

Authors:  Thomas Münzel; Tommaso Gori; Rosa Maria Bruno; Stefano Taddei
Journal:  Eur Heart J       Date:  2010-10-25       Impact factor: 29.983

6.  Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia.

Authors:  Ian Schofield; Rayaz Malik; Ashley Izzard; Clare Austin; Anthony Heagerty
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

7.  Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats.

Authors:  J C Frisbee; D W Stepp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

8.  Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.

Authors:  I Russo; P Del Mese; G Doronzo; L Mattiello; M Viretto; A Bosia; G Anfossi; M Trovati
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

Review 9.  Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  David Montero; Guillaume Walther; Antonia Pérez-Martin; Nestor Vicente-Salar; Enrique Roche; Agnès Vinet
Journal:  Diabetologia       Date:  2013-07-18       Impact factor: 10.122

Review 10.  Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.

Authors:  Michael G Clark
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

View more
  3 in total

1.  Regulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels.

Authors:  Fu Yi; Huan Wang; Qiang Chai; Xiaoli Wang; Win-Kuang Shen; Monte S Willis; Hon-Chi Lee; Tong Lu
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

Review 2.  Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry.

Authors:  Rosa Maria Bruno; Tommaso Gori; Lorenzo Ghiadoni
Journal:  Vasc Health Risk Manag       Date:  2014-09-26

Review 3.  Intima media thickness, pulse wave velocity, and flow mediated dilation.

Authors:  Rosa Maria Bruno; Elisabetta Bianchini; Francesco Faita; Stefano Taddei; Lorenzo Ghiadoni
Journal:  Cardiovasc Ultrasound       Date:  2014-08-23       Impact factor: 2.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.